5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part A
- 1st Edition, Volume 259 - January 29, 2021
- Imprint: Elsevier
- Editors: Giuseppe Di Giovanni, Philippe De Deurwaerdere
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 4 5 6 7 - 5
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 4 5 6 8 - 2
5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance, Part B, Volume 260 in the Progress in Brain Research series, highlights new advanc… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance, Part B, Volume 260 in the Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Serotonin-noradrenalin interactions, Electrophysiological and neurochemical evidence for an interaction of serotonin on noradrenergic neurons, Serotonin and cannabinoid system, 5-HT/CB interaction in the CNS in health and disease, Serotonin2A receptors and Cannabinoids, CB1/5-HT/GABA in food intake, A close interaction between serotonergic system and BDNF in the mechanism of action of antidepressant, 5-HT/ Ach, Interaction of 5-HT2A/2C ligands and nicotine, and more.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in the Progress in Brain Research series
- Includes the latest information on the 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance, Part B
Undergraduates, graduates, academics and researchers in the field of Progress in Brain Research
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- Chapter 1: 5-HT interaction with other neurotransmitters: An overview
- Abstract
- Chapter 2: Role of central serotonin and noradrenaline interactions in the antidepressants’ action: Electrophysiological and neurochemical evidence
- Abstract
- 1: Introduction
- 2: Morpho-physiological aspects of serotonin system
- 3: Morpho-physiological aspects of noradrenergic system
- 4: Inter-modulations of noradrenaline and serotonin systems
- 5: Effects of antidepressant drugs on noradrenaline and serotonin systems
- 6: Other candidates
- 7: Concluding remarks
- Chapter 3: Endocannabinoid-serotonin systems interaction in health and disease
- Abstract
- 1: The endocannabinoid system
- 2: eCB and 5-HT systems
- 3: Cannabinoid/serotonin interaction in psychiatric disorders
- 4: Conclusions
- Acknowledgments
- Chapter 4: Serotonin 2A receptors and cannabinoids
- Abstract
- 1: Introduction
- 2: 5-HT2ARs
- 3: Cannabinoids
- 4: 5-HT2AR and cannabinoids interaction
- 5: 5-HT2AR and cannabinoids interaction in mental disorders
- 6: Conclusions
- Chapter 5: CB1/5-HT/GABA interactions and food intake regulation
- Abstract
- 1: Introduction
- 2: Interaction between cannabinoid 1 receptors and serotonin
- 3: Interactions between GABA and serotonin
- 4: Implications of 5-HT/GABA/CB1 in pathological eating behavior
- 5: Conclusion
- Acknowledgment
- Chapter 6: Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes
- Abstract
- 1: Organization of the serotonergic system and role in the regulation of mood
- 2: Overview of the role of astrocytes in mood disorders
- 3: A tight control of mood and serotonergic system by the main gliotransmitters
- 4: Role of astrocyte neurotrophic factors in mood control and 5-HT pathways
- 5: Conclusion
- Acknowledgments
- Chapter 7: 5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
- Abstract
- 1: Introduction
- 2: Behavioral and biological features of nicotine use and dependence
- 3: 5-HT systems and the treatment of nicotine use and dependence
- 4: Summary and conclusions
- Chapter 8: 5-HT/GABA interaction in epilepsy
- Abstract
- 1: Introduction
- 2: Opposite role of GABA in epilepsy
- 3: Role of serotonin in epilepsy
- 4: Pathophysiology of temporal lobe epilepsy
- 5: 5-HT/GABA control of temporal lobe epilepsy and generalized seizures
- 6: Pathophysiology of absence epilepsy and the role of GABA
- 7: 5-HT/GABA control of ASs
- 8: Concluding remarks
- Acknowledgments
- Chapter 9: 5-HT/GABA interaction in neurodevelopment and plasticity
- Abstract
- 1: Introduction
- 2: The GABAergic system
- 3: 5-HT/GABA role in prenatal neurodevelopment
- 4: 5-HT/GABA role in postnatal development and critical period plasticity
- 5: 5-HT role in adult neurogenesis
- 6: 5-HT and 5-HT/GABA role in adult plasticity
- 7: Concluding remarks
- Acknowledgments
- Edition: 1
- Volume: 259
- Published: January 29, 2021
- No. of pages (Hardback): 332
- No. of pages (eBook): 332
- Imprint: Elsevier
- Language: English
- Hardback ISBN: 9780128245675
- eBook ISBN: 9780128245682
GD
Giuseppe Di Giovanni
Prof. Giuseppe Di Giovanni received his Ph.D. in Neuroscience from the University of Chieti, Italy and was a postdoctoral fellow at Yale University, USA. Previously Senior Lecturer of Human Physiology at the Faculty of Medicine and Surgery, University of Palermo, and Associate Professor at the University of Malta, from 2013 he is Professor of Human Physiology at the Medical School of the University of Malta and from 2018 Honorary Professor at Cardiff University, UK. His research focuses on understanding the pathophysiology of monoaminergic systems using electrophysiological and neurochemical approach. He has published more than 120 peer-reviewed papers, edited 7 books and 6 special issues of various journals.
Affiliations and expertise
University of Malta, MaltaPD
Philippe De Deurwaerdere
Professor Philippe De Deurwaerdère, Centre National de la Recherche Scientifique Bordeaux Cedex France
Affiliations and expertise
Centre National de la Recherche Scientifique, FranceRead 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part A on ScienceDirect